메뉴 건너뛰기




Volumn 10, Issue 11, 2014, Pages 3196-3200

TroVax in colorectal cancer

Author keywords

5T4 antigen; Immunotherapy; Metastatic colon cancer; Modified vaccinia Ankara; TroVax

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; CYTOKINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MODIFIED VACCINIA VIRUS ANKARA 5T4 VACCINE; NAVELBINE; OXALIPLATIN; TG 4010; CAMPTOTHECIN; CANCER VACCINE; MEMBRANE PROTEIN; PLATINUM COMPLEX; TROPHOBLASTIC GLYCOPROTEIN 5T4, HUMAN;

EID: 84921714339     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/21645515.2014.973323     Document Type: Article
Times cited : (18)

References (35)
  • 1
  • 2
    • 84880665721 scopus 로고    scopus 로고
    • Treatment of metastatic colon cancer: "The times they are A- changing."
    • PMID:23630214
    • Kemeny NE. Treatment of metastatic colon cancer: "the times they are A- changing." J Clin Oncol 2013;31:1913-6; PMID:23630214; http://dx.doi.org/10.1200/JCO.2013.49.4500
    • (2013) J Clin Oncol , vol.31 , pp. 1913-1916
    • Kemeny, N.E.1
  • 3
    • 84882455499 scopus 로고    scopus 로고
    • Long term survival after hepatic and pulmonary resection of the colorectal cancer metastases
    • PMID:23893480
    • Sourrouille I, Mordant P, Maggiori L, Dokmak S, Leseche G, Panis Y, Belghiti J, Castier Y. Long term survival after hepatic and pulmonary resection of the colorectal cancer metastases. J Surg Oncol 2013; 108:220-4; PMID:23893480; http://dx.doi.org/10.1002/jso.23385
    • (2013) J Surg Oncol , vol.108 , pp. 220-224
    • Sourrouille, I.1    Mordant, P.2    Maggiori, L.3    Dokmak, S.4    Leseche, G.5    Panis, Y.6    Belghiti, J.7    Castier, Y.8
  • 4
    • 67650136139 scopus 로고    scopus 로고
    • An MVA- based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases
    • PMID:18833005
    • Elkord E, Dangoor A, Drury NL, Harrop R, Burt DJ, Drijfhout JW, Hamer C, Andrews D, Naylor S, Sherlock D, et al. An MVA- based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases. J Immunother 2008; 31:820-9; PMID:18833005; http://dx.doi. org/10.1097/CJI.0b013e3181876ab3
    • (2008) J Immunother , vol.31 , pp. 820-829
    • Elkord, E.1    Dangoor, A.2    Drury, N.L.3    Harrop, R.4    Burt, D.J.5    Drijfhout, J.W.6    Hamer, C.7    Andrews, D.8    Naylor, S.9    Sherlock, D.10
  • 5
    • 84861645912 scopus 로고    scopus 로고
    • The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: A systematic review
    • PMID:22316439
    • Quan D, Gallinger S,Nhan C, AuerRA, Biagi JJ, Fletcher GG, Law CH, Moulton CA, Ruo L, Wei AC, Mcleod RS. The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery 2012; 151:860-70; PMID:22316439; http://dx.doi.org/10.1016/j.surg.2011.12.018
    • (2012) Surgery , vol.151 , pp. 860-870
    • Quan, D.1    Gallinger, S.2    Nhan, C.3    Auer, R.A.4    Biagi, J.J.5    Fletcher, G.G.6    Law, C.H.7    Moulton, C.A.8    Ruo, L.9    Wei, A.C.10    Mcleod, R.S.11
  • 9
    • 84893073441 scopus 로고    scopus 로고
    • Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: A phase II, single-arm trial
    • not203202014; PMID:24335700
    • Bloch O, Crane CA, Fuks Y, Kaur R, Aghi MK, Berger MS, Butowski NA, Chang SM, Clarke JL, McDermott MW, et al. Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, sin-gle-arm trial. Neuro Oncol 2014; 16:274-9. not203202014; PMID:24335700; http://dx.doi.org/10.1093/ neuonc/not203
    • (2014) Neuro Oncol , vol.16 , pp. 274-279
    • Bloch, O.1    Crane, C.A.2    Fuks, Y.3    Kaur, R.4    Aghi, M.K.5    Berger, M.S.6    Butowski, N.A.7    Chang, S.M.8    Clarke, J.L.9    McDermott, M.W.10
  • 10
    • 84891484180 scopus 로고    scopus 로고
    • Secreted heat shock protein gp96-Ig: Next-generation vaccines for cancer and infectious diseases
    • PMID:24254084
    • Strbo N, Garcia-Soto A, Schreiber TH, Podack ER. Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases. Immunol Res 2013; 57:311-25; PMID:24254084; http://dx.doi. org/10.1007/s12026-013-8468-x
    • (2013) Immunol Res , vol.57 , pp. 311-325
    • Strbo, N.1    Garcia-Soto, A.2    Schreiber, T.H.3    Podack, E.R.4
  • 11
    • 84879097715 scopus 로고    scopus 로고
    • REO-001: A phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin) in patients with advanced solid tumors
    • PMID:22886613
    • Morris DG, Feng X, DiFrancesco LM, Fonseca K, Forsyth PA, Paterson AH, Coffey MC, Thompson B. REO-001: a phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin) in patients with advanced solid tumors. Invest New Drugs 2013; 31:696-706; PMID:22886613; http://dx.doi. org/10.1007/s10637-012-9865-z
    • (2013) Invest New Drugs , vol.31 , pp. 696-706
    • Morris, D.G.1    Feng, X.2    DiFrancesco, L.M.3    Fonseca, K.4    Forsyth, P.A.5    Paterson, A.H.6    Coffey, M.C.7    Thompson, B.8
  • 12
    • 84903208336 scopus 로고    scopus 로고
    • PD-1 pathway inhibitors: Changing the landscape of cancer immunotherapy
    • PMID:24955707
    • Dolan DE, Gupta S. PD-1 pathway inhibitors: changing the landscape of cancer immunotherapy. Cancer Control 2014; 21:231-37; PMID:24955707
    • (2014) Cancer Control , vol.21 , pp. 231-237
    • Dolan, D.E.1    Gupta, S.2
  • 13
    • 84858766182 scopus 로고    scopus 로고
    • The blockade of immune checkpoints in cancer immunotherapy
    • Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev 2012; 12:251-64.
    • (2012) Nat Rev , vol.12 , pp. 251-264
    • Pardoll, D.M.1
  • 14
    • 84888237576 scopus 로고    scopus 로고
    • Identification of pre- and post-treatment markers, clinical, and laboratory parameters associated with outcome in renal cell cancer patients treated with MVA-5T4
    • PMID:23875174
    • Said R, mato RJ. Identification of pre- and post-treatment markers, clinical, and laboratory parameters associated with outcome in renal cell cancer patients treated with MVA-5T4. FrontOncol 2013; 3:185; PMID:23875174; http://dx.doi.org/10.3389/fonc.2013.00185
    • (2013) FrontOncol , vol.3 , pp. 185
    • Said, R.1    Mato, R.J.2
  • 15
    • 80053378780 scopus 로고    scopus 로고
    • Viral vector-based therapeutic cancer vaccines
    • Larocca C, chlom J. Viral vector-based therapeutic cancer vaccines. Cancer J 2011; 5:359-71; http://dx.doi. org/10.1097/PPO.0b013e3182325e63
    • (2011) Cancer J , vol.5 , pp. 359-371
    • Larocca, C.1    Chlom, J.2
  • 16
    • 78649369270 scopus 로고    scopus 로고
    • TroVax, a recombinant modified vaccinia Ankara virus encoding 5T4- lessons learned and future development
    • PMID:20975327
    • Kim DW, Krishnamurthy V, Bines SB, Kaufman HL. TroVax, a recombinant modified vaccinia Ankara virus encoding 5T4- lessons learned and future development. Hum Vaccin 2010; 6:784-91; PMID:20975327; http://dx.doi.org/10.4161/hv.6.10.13144
    • (2010) Hum Vaccin , vol.6 , pp. 784-791
    • Kim, D.W.1    Krishnamurthy, V.2    Bines, S.B.3    Kaufman, H.L.4
  • 17
    • 33745223435 scopus 로고    scopus 로고
    • Vaccination of colorectal cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease Control: A phase III trial
    • PMID:16740766
    • Harrop R, Connolly N, Redchenko I, Valle J, Saunders M, Ryan MG, Myers KA, Drury N, Kingsman SM, Hawkins RE, et al. Vaccination of colorectal cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease Control: a phase III trial. Clin Cancer Res 2006; 12:3416-24; PMID:16740766; http://dx.doi.org/10.1158/1078-0432.CCR-05-2732
    • (2006) Clin Cancer Res , vol.12 , pp. 3416-3424
    • Harrop, R.1    Connolly, N.2    Redchenko, I.3    Valle, J.4    Saunders, M.5    Ryan, M.G.6    Myers, K.A.7    Drury, N.8    Kingsman, S.M.9    Hawkins, R.E.10
  • 18
    • 34547652648 scopus 로고    scopus 로고
    • Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses
    • PMID:17671134
    • Harrop R, Drury N, Shingler W, Chikoti P, Redchenko I, Carroll MW, Kingsman SM, Naylor S, Melcher A, Nicholls J, et al. Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses. Clin Cancer Res 2007; 13:4487-94; PMID:17671134; http://dx.doi.org/10.1158/1078-0432.CCR-07-0704
    • (2007) Clin Cancer Res , vol.13 , pp. 4487-4494
    • Harrop, R.1    Drury, N.2    Shingler, W.3    Chikoti, P.4    Redchenko, I.5    Carroll, M.W.6    Kingsman, S.M.7    Naylor, S.8    Melcher, A.9    Nicholls, J.10
  • 19
    • 42649138944 scopus 로고    scopus 로고
    • Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin an irinotecan) is safe and induced potent immune responses
    • PMID:18060404
    • Harrop R, Noel Drury W, Shingler P, Chikoti I, Redchenko I, Carroll MW, Kingsman SM, Naylor S, Griffiths R, Steven N, et al. Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin an irinotecan) is safe and induced potent immune responses. Cancer Immunol Immunother 2008; 57:977-86; PMID:18060404; http://dx.doi.org/10.1007/s00262-007-0428-7
    • (2008) Cancer Immunol Immunother , vol.57 , pp. 977-986
    • Harrop, R.1    Noel Drury, W.2    Shingler, P.3    Chikoti, I.4    Redchenko, I.5    Carroll, M.W.6    Kingsman, S.M.7    Naylor, S.8    Griffiths, R.9    Steven, N.10
  • 20
    • 79151471986 scopus 로고    scopus 로고
    • A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal cell-clear-cell carcinoma: Clinical and immunological findings
    • Oudard S, Rixe O, Beuselinck B, Linassier C, Banu E, Machiels JP, Baudard M, Ringeisen F, Velu T, Lefrere-Belda MA, et al. A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal cell-clear-cell carcinoma: clinical and immunological findings. Cancer Immuno Immunother 2011; 60:261-71; http://dx.doi.org/10.1007/s00262-010-0935-9
    • (2011) Cancer Immuno Immunother , vol.60 , pp. 261-271
    • Oudard, S.1    Rixe, O.2    Beuselinck, B.3    Linassier, C.4    Banu, E.5    Machiels, J.P.6    Baudard, M.7    Ringeisen, F.8    Velu, T.9    Lefrere-Belda, M.A.10
  • 21
    • 67651173157 scopus 로고    scopus 로고
    • MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure
    • PMID:18931824
    • Dreicer R, Stadler WM, Ahmann FR, Whiteside T, Bizouarne N, Acres B, Limacher JM, Squiban P, Pantuck A. MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure. Invest New Drugs 2009; 27:379-86; PMID:18931824; http://dx.doi.org/10.1007/s10637-008-9187-3
    • (2009) Invest New Drugs , vol.27 , pp. 379-386
    • Dreicer, R.1    Stadler, W.M.2    Ahmann, F.R.3    Whiteside, T.4    Bizouarne, N.5    Acres, B.6    Limacher, J.M.7    Squiban, P.8    Pantuck, A.9
  • 22
    • 50349090322 scopus 로고    scopus 로고
    • A phase II study of TG4010 (MVA-MUC1-IL1) in association with chemotherapy in patients with Stage IIIIV Non-Small Cell Lung cancer
    • PMID:18594319
    • Ramlau R, Quoix E, Rolski J, Pless M, Lena H, Levy E, Krzakowski M, Hess D, Tartour E, Chenard MP, et al. A phase II study of TG4010 (MVA-MUC1-IL1) in association with chemotherapy in patients with Stage IIIIV Non-Small Cell Lung cancer. J Thorac Oncol 2008; 3:735-44; PMID:18594319; http://dx.doi.org/10.1097/JTO.0b013e31817c6b4f
    • (2008) J Thorac Oncol , vol.3 , pp. 735-744
    • Ramlau, R.1    Quoix, E.2    Rolski, J.3    Pless, M.4    Lena, H.5    Levy, E.6    Krzakowski, M.7    Hess, D.8    Tartour, E.9    Chenard, M.P.10
  • 27
    • 84865552100 scopus 로고    scopus 로고
    • Immuno-oncology: Understanding the function and dysfunction of the immune system in cancer
    • PMID:22918931
    • Finn OJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol 2012; 23 (supplement 8): viii6-9; PMID:22918931
    • (2012) Ann Oncol , vol.23 , pp. viii6-viii9
    • Finn, O.J.1
  • 28
    • 18344375283 scopus 로고    scopus 로고
    • Immunotherapy and chemotherapy - A practical partnership
    • PMID:15864281
    • Lake RA, Robinson BW. Immunotherapy and chemotherapy-a practical partnership. Nat Rev Cancer 2005;5:397-405; PMID:15864281
    • (2005) Nat Rev Cancer , vol.5 , pp. 397-405
    • Lake, R.A.1    Robinson, B.W.2
  • 29
    • 67449085969 scopus 로고    scopus 로고
    • Vaccination of patients with metastatic renal cancer with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax) given alongside interferonalpha
    • PMID:19342962
    • Hawkins RE, MacDermott C, Shablak A, Hamer C, Thistlethwaite F, DruryNL, Chikoti P, ShinglerW,Naylor S, Harrop R. Vaccination of patients with metastatic renal cancer with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax) given alongside interferonalpha. J Immunother 2009; 32:424-9; PMID:19342962; http://dx.doi.org/10.1097/CJI.0b013e31819d297e
    • (2009) J Immunother , vol.32 , pp. 424-429
    • Hawkins, R.E.1    MacDermott, C.2    Shablak, A.3    Hamer, C.4    Thistlethwaite, F.5    Drury, N.L.6    Chikoti, P.7    Shingler, W.8    Naylor, S.9    Harrop, R.10
  • 30
    • 68449100522 scopus 로고    scopus 로고
    • Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered with interferon-alpha (IFN-alpha): A phase 2 trial
    • PMID:19561532
    • Amato RJ, Shingler W, Goonewardena M, de Belin J, Naylor S, Jac J, Willis J, Saxena S, Hernandez-McClain J, Harrop R. Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered with interferon-alpha (IFN-alpha): a phase 2 trial. J Immunother 2009; 32:765-72; PMID:19561532; http://dx. doi.org/10.1097/CJI.0b013e3181ace876
    • (2009) J Immunother , vol.32 , pp. 765-772
    • Amato, R.J.1    Shingler, W.2    Goonewardena, M.3    De Belin, J.4    Naylor, S.5    Jac, J.6    Willis, J.7    Saxena, S.8    Hernandez-McClain, J.9    Harrop, R.10
  • 31
    • 58149354757 scopus 로고    scopus 로고
    • Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: A phase II trial
    • PMID:19010868
    • Amato RJ, Shingler W, Naylor S, Jac J, Willis J, Saxena S, Hernandez-McClain J, Harrop R. Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: a phase II trial. Clin Cancer Res 2008; 14:7504-10; PMID:19010868; http://dx.doi. org/10.1158/1078-0432.CCR-08-0668
    • (2008) Clin Cancer Res , vol.14 , pp. 7504-7510
    • Amato, R.J.1    Shingler, W.2    Naylor, S.3    Jac, J.4    Willis, J.5    Saxena, S.6    Hernandez-McClain, J.7    Harrop, R.8
  • 32
    • 60549106426 scopus 로고    scopus 로고
    • Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma
    • PMID:19128501
    • Kaufman H, Taback B, Sherman W, Kim DW, Shingler WH, Moroziewicz D, DeRaffele G, Mitcham J, Carroll MW, Harrop R, et al. Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma. J Transl Med 2009; 7:2; PMID:19128501; http://dx.doi.org/10.1186/1479-5876-7-2
    • (2009) J Transl Med , vol.7 , pp. 2
    • Kaufman, H.1    Taback, B.2    Sherman, W.3    Kim, D.W.4    Shingler, W.H.5    Moroziewicz, D.6    DeRaffele, G.7    Mitcham, J.8    Carroll, M.W.9    Harrop, R.10
  • 33
    • 48549088424 scopus 로고    scopus 로고
    • Vaccination of prostate cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax): A phase 2 trial
    • PMID:18528296
    • Amato RJ, Drury N, Naylor S, Jac J, Saxena S, Cao A, Hernandez-McClain J,Harrop R. Vaccination of prostate cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax): a phase 2 trial. J Immunother 2008; 31:577-85; PMID:18528296; http://dx.doi.org/10.1097/CJI.0b013e31817deafd
    • (2008) J Immunother , vol.31 , pp. 577-585
    • Amato, R.J.1    Drury, N.2    Naylor, S.3    Jac, J.4    Saxena, S.5    Cao, A.6    Hernandez-McClain, J.7    Harrop, R.8
  • 35
    • 15944410592 scopus 로고    scopus 로고
    • Inhibition of CD4 (C) 25 CT regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
    • PMID:15591121
    • Lutsiak ME, Semnani RT, De Pascalis R, Kashmiri SV, Schlom J, Sabzevari H. Inhibition of CD4 (C) 25 CT regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood 2005; 105:2862-8; PMID:15591121; http://dx.doi.org/10.1182/blood-2004-06-2410
    • (2005) Blood , vol.105 , pp. 2862-2868
    • Lutsiak, M.E.1    Semnani, R.T.2    De Pascalis, R.3    Kashmiri, S.V.4    Schlom, J.5    Sabzevari, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.